4//SEC Filing
Freeman Roy Lester 4
Accession 0000950170-23-031850
CIK 0001750149other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:11 PM ET
Size
5.1 KB
Accession
0000950170-23-031850
Insider Transaction Report
Form 4
Freeman Roy Lester
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-30+6,667→ 6,667 totalExercise: $3.61Exp: 2030-06-30→ Common Stock (6,667 underlying)
Footnotes (1)
- [F1]The options will vest on the earlier of June 30, 2024 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001799732
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 9:11 PM ET
- Size
- 5.1 KB